Physostigmine in 1999: tolerability, indications and availability.
Ries
C R
CR
D018686:Anesthetics, Intravenous / Q000037:antagonists & inhibitors*; D006801:Humans; D010277:Parasympathomimetics / Q000009:adverse effects*; D010830:Physostigmine / Q000009:adverse effects*; D015742:Propofol / Q000037:antagonists & inhibitors*
D018686:Anesthetics, Intravenous; D010277:Parasympathomimetics; D010830:Physostigmine; D015742:Propofol